Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Staphylococcal prosthetic joint infection 

Staphylococcal prosthetic joint infection
Chapter:
Staphylococcal prosthetic joint infection
Author(s):

Kate El Bouzidi

DOI:
10.1093/med/9780199665754.003.0021
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 28 June 2022

Prosthetic joint infection (PJI) is a catastrophic complication and the majority of cases are caused by coagulase-negative staphylococci or Staphylococcus aureus. Staphylococci adhere to native bone and prostheses and can form biofilms to protect against the host immune response and antibiotic penetration. Diagnosis may be difficult in the absence of fever and raised inflammatory markers, and radiology findings are often non-specific. A microbiological diagnosis may be obtained by tissue cultures or newer techniques such as sonication and PCR. The infection in the case was identified as methicillin-sensitive Staphylococcus aureus (MSSA). Different surgical strategies available to manage prosthetic joint infection are discussed including one- and two-stage revision arthroplasty, DAIR (debridement, antibiotics, and implant retention), and the use of antibiotic-eluting spacers and cement. There is controversy regarding the choice, duration, and route of administration of antibiotic therapy and whether prolonged systemic therapy is required at all. PJI creates a significant economic burden and infection control procedures are imperative to reduce the impact on patients and healthcare resources.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.